Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development

Philip J. Stephens(Wellcome Sanger Institute), Chris Greenman(Wellcome Sanger Institute), Beiyuan Fu(Wellcome Sanger Institute), Fengtang Yang(Wellcome Sanger Institute), Graham R. Bignell(Wellcome Sanger Institute), Laura Mudie(Wellcome Sanger Institute), Erin Pleasance(Wellcome Sanger Institute), King Wai Lau(Wellcome Sanger Institute), David Beare(Wellcome Sanger Institute), Lucy Stebbings(Wellcome Sanger Institute), Stuart McLaren(Wellcome Sanger Institute), Meng‐Lay Lin(Wellcome Sanger Institute), David J. McBride(Wellcome Sanger Institute), Ignacio Varela(Wellcome Sanger Institute), Serena Nik‐Zainal(Wellcome Sanger Institute), Catherine Leroy(Wellcome Sanger Institute), Mingming Jia(Wellcome Sanger Institute), Andrew Menzies(Wellcome Sanger Institute), Adam P. Butler(Wellcome Sanger Institute), Jon W. Teague(Wellcome Sanger Institute), Michael A. Quail(Wellcome Sanger Institute), John H. Burton(Wellcome Sanger Institute), Harold Swerdlow(Wellcome Sanger Institute), Nigel P. Carter(Wellcome Sanger Institute), Laura Morsberger(Johns Hopkins University), Christine A. Iacobuzio–Donahue(Johns Hopkins University), George Follows(Addenbrooke's Hospital), Anthony R. Green(University of Cambridge), Adrienne M. Flanagan(Royal National Orthopaedic Hospital), Michael R. Stratton(Institute of Cancer Research), P. Andrew Futreal(Wellcome Sanger Institute), Peter J. Campbell(University of Cambridge)
Cell
January 1, 2011
Cited by 2,434Open Access
Full Text

Abstract

Cancer is driven by somatically acquired point mutations and chromosomal rearrangements, conventionally thought to accumulate gradually over time. Using next-generation sequencing, we characterize a phenomenon, which we term chromothripsis, whereby tens to hundreds of genomic rearrangements occur in a one-off cellular crisis. Rearrangements involving one or a few chromosomes crisscross back and forth across involved regions, generating frequent oscillations between two copy number states. These genomic hallmarks are highly improbable if rearrangements accumulate over time and instead imply that nearly all occur during a single cellular catastrophe. The stamp of chromothripsis can be seen in at least 2%-3% of all cancers, across many subtypes, and is present in ∼25% of bone cancers. We find that one, or indeed more than one, cancer-causing lesion can emerge out of the genomic crisis. This phenomenon has important implications for the origins of genomic remodeling and temporal emergence of cancer.


Related Papers